Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Robert Epstein, Bruce Huebner

Premium

Illumina announced recently that Robert Epstein has joined its board of directors. Epstein formerly was chief R&D officer and president of Medco-UBC, and he was Medco’s chief medical officer for 13 years.

He also served as president of the International Society of Pharmacoeconomics and Outcomes Research, and he was on the board of directors of the Drug Information Association and the International Society of Quality of Life.


Vermillion has tapped Bruce Huebner to be its interim CEO, taking over for exiting CEO Gail Page, who will serve the company as a strategic advisor. The company's board has formed a succession committee and retained an executive search firm to find a new CEO to fill the post long-term.

Huebner will continue to serve on the company's board of directors as he handles the added interim-CEO duties. His executive management experience includes stints as president of Osmetech, now GenMark Diagnostics; president and CEO of Nanogen; and as executive vice president and chief operating officer at Gen-Probe.

The Scan

Plan Rebuffed

The Associated Press reports China has rejected the World Health Organization's proposal to include the lab-leak theory in the next phase of its investigation into the origins of SARS-CoV-2.

Opossum Change

Researchers from Riken have used CRISPR to edit marsupial genomes, as Technology Review reports.

In the Ice

Cosmos magazine reports that researchers have uncovered more than two dozen ancient viruses in a Tibetan glacier.

Nature Papers Present Method to Uncover Differential RNA Modifications, Neutrophils in Innate Immune Response

In Nature this week: computational approach to identifying differential RNA modifications, and more.